• FirefoxInstall the new Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.74%

    Agenus Inc. (AGEN)

    -NasdaqCM
    4.84 Down 0.04(0.84%) 2:00PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.88
    Open:4.85
    Bid:4.82 x 100
    Ask:4.83 x 400
    1y Target Est:9.25
    Beta:1.05
    Earnings Date:Mar 3 - Mar 9 (Est.)
    Day's Range:4.76 - 4.93
    52wk Range:2.27 - 6.49
    Volume:438,966
    Avg Vol (3m):2,197,410
    Market Cap:303.33M
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AGENDown 0.84%303.33M
    ABPI 0.00%N/A
    DNDNDown 13.61%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):43.84
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Mar-15) :-0.01
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback